The Retinal Degeneration Fund – the venture arm of the Foundation Fighting Blindness aimed at rapidly driving research to...
Read more
The Gut Microbiome May Unlock New Treatment Paradigms For Neurological Diseases – Axial Therapeutics
Autistic children have long been known to have differences in their gut microbiota and as a result are more...
Read more
Axial Therapeutics announced completion of enrollment in the TAPESTRY Autism Study, the Phase 2b clinical trial of its lead...
Read more
Behavioral Signals announced that it has been recognized by Gartner in Six (6) Hype Cycle 2023 reports, in addition...
Read more
MemVerge® introduced QEMU-based CXL Flight Simulator, a virtual CXL hardware environment that allows software engineers to kick off development without...
Read more
Actuate Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for elraglusib...
Read more
Foldax announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial...
Read more
In recent years, the global community has been increasingly concerned about the detrimental impacts of conventional pest control methods...
Read more
Kairos Ventures is pleased to announce that Northwestern University Professor Mercouri Kanatzidis, the founder of our portfolio company Actinia, Inc., has received another...
Read more
Northwestern University Professor Mercouri Kanatzidis, who was elected to the American Academy of Arts & Sciences earlier this year,...
Read more